November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Iván R. González: Warning on Sotorasib Treatment for Advanced Lung Cancer
Nov 14, 2024, 15:58

Iván R. González: Warning on Sotorasib Treatment for Advanced Lung Cancer

Iván R. González, Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla, shared on X:

“Warning on Sotorasib Treatment for Advanced Lung Cancer.

Sotorasib, the first RAS inhibitor approved for KRASG12C-mutated NSCLC, showed improvements in progression-free survival (PFS) in the CodeBreaK 200 trial. However, in October 2023, the FDA rejected its regular approval, keeping its accelerated status pending confirmatory studies.

A 2023 commentary in The Lancet raises concerns about the trial’s statistical analysis and the absolute risks for PFS and overall survival (OS).

Transparency in these studies is essential to properly guide clinical practice.”

Iván R. González